Conditions
After a new diagnosis, start with orientation
Plain-language guidance for what the condition is, what usually happens next, and what to ask your doctor. We build these hubs one condition at a time — calm, reviewed, and easy to scan when you don’t have time to read everything.
This isn’t a medical encyclopedia. It’s a starting place after the appointment.
Wave 1 · Oncology
The first hubs we’re bringing through review
High-need cancers where clear orientation matters early. Each page goes through editorial and medical review before it’s published — when you see “Available,” a qualified clinician has read it.
Breast cancer
In editorial reviewA cancer that starts in the cells of the breast. Type, stage, and your overall health shape treatment and next steps.
Preview in reviewColorectal cancer
In editorial reviewA cancer that starts in the colon or rectum. Treatment depends on where it starts, how far it has spread, and the specific tumor features.
Preview in reviewNon-small cell lung cancer
In editorial reviewThe most common form of lung cancer. Subtype, stage, and biomarker test results shape which treatments are considered.
Preview in review
Wave 2 · Expanded coverage
More oncology and conditions we see in intake every week
Same hub structure and review bar as Wave 1 — broader cancer coverage plus cardiometabolic, kidney, and memory conditions patients often look up right after a diagnosis.
Alzheimer’s disease and mild cognitive impairment
In editorial reviewMCI is a measurable decline in thinking that may or may not progress. Alzheimer’s is the most common cause of progressive dementia—diagnosis and subtype guide treatment and planning.
Preview in reviewChronic kidney disease
In editorial reviewLong-term loss of kidney filtering ability, often silent until advanced. Stage, cause, and urine protein guide how often you’re monitored and which drugs are adjusted.
Preview in reviewHeart failure
In editorial reviewA syndrome where the heart can’t pump or fill well enough for the body’s needs. Type, severity, and symptoms shape medications, devices, and follow-up.
Preview in reviewMelanoma
In editorial reviewA skin cancer that starts in pigment-making cells. Depth, spread to lymph nodes or elsewhere, and molecular test results guide surgery, immunotherapy, or targeted drugs.
Preview in reviewOvarian cancer
In editorial reviewCancers that start in or on the ovaries or related tissues. Subtype and stage determine whether surgery, chemotherapy, targeted therapy, or a combination is discussed first.
Preview in reviewPancreatic cancer
In editorial reviewA cancer that starts in the pancreas. Where it sits in the pancreas and whether it can be removed with surgery guide the first conversations about treatment.
Preview in reviewProstate cancer
In editorial reviewA cancer that starts in the prostate gland. Risk group, stage, and your goals for quality of life shape whether active surveillance or treatment is recommended.
Preview in reviewType 2 diabetes
In editorial reviewA long-term condition where the body resists insulin or doesn’t make enough. A1C, kidney function, and heart risk guide medication and follow-up.
Preview in review
Wave 3 · On the roadmap
Coming soon
Planned topics not yet in the editorial queue. When a hub graduates, it will show up in Wave 1 or 2 with the same reviewed structure — until then, intake and trial search still work in your own words.
Multiple myeloma
Coming soonPlasma cell cancer — staging, bone complications, and modern therapy lines explained for patients.
Page not yet scheduledLymphoma
Coming soonHodgkin and non-Hodgkin types, staging scans, and how treatment intensity is chosen.
Page not yet scheduledBladder cancer
Coming soonFrom first symptoms through intravesical therapy, surgery, and systemic options.
Page not yet scheduledThyroid nodules & cancer
Coming soonWhat biopsy results mean, surveillance vs. surgery, and hormone therapy after treatment.
Page not yet scheduledCOPD
Coming soonFlare prevention, inhaler plans, oxygen when needed, and pulmonary rehab in plain language.
Page not yet scheduledInflammatory bowel disease
Coming soonCrohn’s disease and ulcerative colitis — flares, scopes, biologics, and surgery decisions.
Page not yet scheduledRheumatoid arthritis
Coming soonEarly treatment goals, DMARDs and biologics, joint protection, and monitoring labs.
Page not yet scheduled
What’s on each page
The same structure, every time
So you learn how to navigate the site once, not every time.
In plain language
What the condition is, without jargon. Short, honest, and oriented to someone reading it for the first time.
What patients usually want to know first
Urgency, which doctor treats it, and what usually happens after the diagnosis conversation.
Symptoms that matter
Common symptoms, less common ones, and red-flag signs that need same-day attention.
What happens after diagnosis
Likely tests, referrals, and staging or subtype workup — in the order they usually come.
Questions to ask your doctor
Practical prompts for your next appointment. Not a script — a starting point.
Treatment pathways
Common treatment routes in plain language. Your care team decides what fits you.
Types, stages, or subconditions
Why the specific type or stage can matter for what comes next.
Research and clinical trials
When research may matter — shown later on each page, after the basics are clear.
How we keep it honest
Reviewed by people. Not a chatbot pretending to be a doctor.
Visible medical review
Every published page names the reviewing clinician and the last review date.
Guideline-level sources
We prefer patient-trusted and guideline-level references, listed on each page.
Not medical advice
These pages help you prepare for conversations with your care team — they don't replace them.
Don’t see your condition yet?
We’re expanding in waves. In the meantime, you can start the intake in your own words — matching works across thousands of trials regardless of whether the guidance page is live.